Quince Therapeutics

Public

Quince Therapeutics is now publicly traded

The data on this page reflects Quince Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jun 11, 2026

Total Funding Raised

$114.72M

Company Overview

Quince Therapeutics is a biotechnology company that acquires, develops, and commercializes therapeutics for debilitating and rare diseases.

AI Layer

Application

Keywords

reverse mergerpublic shell companycash shellrare disease therapeuticsorphan drugsclinical-stage biotechdrug developmentAI drug discoveryAtaxia-TelangiectasiaA-Tneurodegenerative diseasedrug repurposingdrug/device combination

Quince Therapeutics Comparables

Compare Quince Therapeutics with similar companies based on industry and business-model similarity.

Quince Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Keystone Bio	32%

View all Comparables

Quince Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jun 11, 2026

View all Funding Rounds

Quince Therapeutics Investors

Notable investors and investment history

Quince Therapeutics investors
Investor	Rounds
Janus Henderson Group	Private Placement
Balyasny Asset Management L.P.	Private Placement
LifeSci Venture Partners	Private Placement
Columbia Threadneedle Investments	Private Placement
Perceptive Advisors	Private Placement
Eventide Funds	Private Placement
Coastlands Capital LP	Private Placement

View all Investors

Quince Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Quince Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range21

Year Founded2012

Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.